MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Phenomenology of Coenzyme Q10-deficiency Spinocerebellar Ataxia: Case Description Of Two Siblings And New Therapeutic Perspectives

S. Cartella, S. Bertino, A. Gardin, S. Neri, A. Battaglia, G. Foti, C. Terranova, G. Cartella, A. Quartarone (Reggio Calabria, Italy)

Meeting: 2024 International Congress

Abstract Number: 1736

Keywords: Ataxia: Genetics, Ataxia: Treatment, Rehabilitation

Category: Rare Genetic and Metabolic Diseases

Objective: To describe the phenomenology of SCAR9, caused by a homozygotic mutation in COQ8A gene, and to describe the positive effects of a holistic approach to the treatment.

Background: Coenzyme Q10 deficiency causes a variety of rare genetic conditions. Autosomal recessive spinocerebellar ataxia 9 (SCAR9) is caused by mutations of COQ8A gene, characterized by dystonia, epilepsy, tremor and ataxia.

Method: Description of two siblings carrying the same homozygotic mutation and presenting with different phenomenology.

Results: A 21-year-old boy presented with a complex neurologic syndrome, started 6 years previously with exercise intolerance, rigidity of the right lower limb, myoclonus of the upper limbs, head and right lower limb, dystonia of the feet, dystonic posture of the hands and episodes characterized by stereotyped behaviours and visual hallucinations, as well as episodes characterized by jerks of the right side of his face, which lasted some seconds. We performed: abdomen ultrasound (hepatomegaly), EMG, EEG, ophthalmologic assessment, urine copper, lumbar puncture, autoimmune assessment, levodopa challenge, brain MRI, neuropsychological tests (all normal) and genetic testing, which enabled us to make the diagnosis. Our approach to treatment is a holistic one, since it involves rehabilitation, both physical and cognitive, logopaedic sessions, pharmacologic treatment and botulinum toxin injections. We have been following him up for four years. His cognition is now affected as well (prominent visuo-spatial deficits and executive dysfunction). He undergoes cycles of worsening and improving, and he still has an optimal response to treatment. His younger brother never complained of any neurological symptom. Nevertheless, on neurological examination he showed: polykinetic reflexes, Babinski sign, postural and kinetic tremor, dystonic posture of the hands, frenage on finger-nose test. We performed neuropsychological evaluation (normal), brain MRI (cerebellar atrophy) and genetic testing (positive). We treat him with ubidecarenone and physical activity, and we have not seen any neurological worsening in our six-months follow-up.

Conclusion: SCAR9 is a rare neurological disorder, presenting with a heterogeneous phenomenology. Making an early diagnosis is of paramount importance in order to ensure early treatment with a holistic approach to patients.

References: 1. Alcazar-Fabra Maria, Brea-Calvo Gloria, Clinical syndromes associated with Coenzyme Q10 deficiency, Essays in Biochemistry (2018) 62 377–398, doi 10.1042/EBC20170107
2. Alcazar-Fabra Maria, Rodriguez-Sanchez Francisco, Trevisson Eva, Brea-Calvo Gloria, Primary Coenzyme Q10 deficiencies; a literature review and online platform of clinical features to uncover genotype-phenotype correlations, Free Radical Biology and Medicine 167 (2021) 141–180, doi 0.1016/j.freeradbiomed.2021.02.046
3. Balreira Andrea, Boczonadin Veronika, Barca Emanuele, Pyle Angela, Bansagi Boglarka, Appleton Marie, Graham Claire, Hargreaves Iain P, Milic Rasic Vedrana, Lochmuller Hanns, Griffin Helen, Taylor Robert W, Naini A, Chinnery Patrick F, Hirano Michio, Quinzii Catarina M, Horvath Rita, ANO10 mutations cause ataxia and Coenzyme Q10 deficiency, J Neurol (2014) 261:2192–2198 DOI 10.1007/s00415-014-7476-7
4. Chang Anna, Ruiz-Lopez Marta, Slow Elizabeth, Tarnopolsky Mark, Lang Anthony E, Munhoz Renato P, ADCK3-related Coenzyme Q10 deficiency: a potentially treatable genetic disease, Mov Dis Clin Pract 2018; 5(6): 635–639. doi: 10.1002/mdc3.12667
5. Galosi Serena, Barca Emanuele, Carrozzo Rosalba, Schirinzi Tommaso, Quinzii Catarina Maria, Lieto Maria, Vasco Gessica, Zanni Ginevra, Di Nottia Michela, Galatolo Daniele, Filla Alessandro, Bertini Enrico, Santorelli Filippo Maria, Leuzzi Vincenzo, Haas Richard, Hirano Michio, Friedman Jennifer, Dystonia-Ataxia with early handwriting deterioration in COQ8A mutation carriers: a case series and literature review, Park Rel Dis 68 (2019) 8-16, doi /10.1016/j.parkreldis.2019.09.015

To cite this abstract in AMA style:

S. Cartella, S. Bertino, A. Gardin, S. Neri, A. Battaglia, G. Foti, C. Terranova, G. Cartella, A. Quartarone. Phenomenology of Coenzyme Q10-deficiency Spinocerebellar Ataxia: Case Description Of Two Siblings And New Therapeutic Perspectives [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/phenomenology-of-coenzyme-q10-deficiency-spinocerebellar-ataxia-case-description-of-two-siblings-and-new-therapeutic-perspectives/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/phenomenology-of-coenzyme-q10-deficiency-spinocerebellar-ataxia-case-description-of-two-siblings-and-new-therapeutic-perspectives/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley